$ONC
BeiGene, Ltd. Stock $onc

$onc Overview Financials Valuation SEC Filings Company Website

2020 Q1 Form 10-Q Financial Statement

#000165130820000056 Filed on May 11, 2020

Income Statement

Concept	2020 Q1	2019 Q1
Revenue	$52.06M	$77.83M
YoY Change	-33.11%	139.16%
Cost Of Revenue	$14.15M	$15.26M
YoY Change	-7.29%	235.41%
Gross Profit	$37.91M	$62.57M
YoY Change	-39.41%	123.52%
Gross Profit Margin	72.82%	80.39%
Selling, General & Admin	$107.1M	$57.65M
YoY Change	85.76%	99.36%
% of Gross Profit	282.46%	92.13%
Research & Development	$304.3M	$178.4M
YoY Change	70.62%	62.58%
% of Gross Profit	802.7%	285.03%
Depreciation & Amortization	$7.750M	$3.416M
YoY Change	126.87%	52.23%
% of Gross Profit	20.44%	5.46%
Operating Expenses	$411.4M	$236.0M
YoY Change	74.32%	70.25%
Operating Profit	-$373.8M	-$173.8M
YoY Change	115.11%	56.81%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$3.681M	$1.728M
YoY Change	113.02%	137.04%
Pretax Income	-$363.4M	-$167.6M
YoY Change	116.88%	54.38%
Income Tax	$1.554M	$519.0K
% Of Pretax Income
Net Earnings	-$363.7M	-$167.6M
YoY Change	116.97%	60.27%
Net Earnings / Revenue	-698.7%	-215.38%
Basic Earnings Per Share	-$0.36
Diluted Earnings Per Share	-$0.36
COMMON SHARES
Basic Shares Outstanding	1.005B shares	776.1M shares
Diluted Shares Outstanding	1.005B shares

Balance Sheet

Concept	2020 Q1	2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.374B
YoY Change
Cash & Equivalents	$1.957B	$764.5M
Short-Term Investments	$1.417B
Other Short-Term Assets
YoY Change
Inventory	$28.78M	$13.14M
Prepaid Expenses
Receivables	$65.62M	$58.98M
Other Receivables	$6.414M
Total Short-Term Assets	$3.595B	$1.797B
YoY Change	100.1%
LONG-TERM ASSETS
Property, Plant & Equipment	$240.3M	$197.8M
YoY Change	21.5%
Goodwill	$109.0K	$109.0K
YoY Change	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$94.25M	$58.61M
YoY Change	60.82%	309.05%
Total Long-Term Assets	$472.0M	$375.5M
YoY Change	25.71%
TOTAL ASSETS
Total Short-Term Assets	$3.595B	$1.797B
Total Long-Term Assets	$472.0M	$375.5M
Total Assets	$4.067B	$2.172B
YoY Change	87.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$98.36M	$105.3M
YoY Change	-6.6%
Accrued Expenses	$179.3M	$99.53M
YoY Change	80.19%
Deferred Revenue		$17.50M
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due	$11.30M	$8.940M
YoY Change	26.38%
Total Short-Term Liabilities	$451.8M	$238.8M
YoY Change	89.19%
LONG-TERM LIABILITIES
Long-Term Debt	$81.91M	$77.48M
YoY Change	5.72%
Other Long-Term Liabilities	$45.31M	$47.92M
YoY Change	-5.46%	118.13%
Total Long-Term Liabilities	$788.4M	$310.7M
YoY Change	153.7%	1314.47%
TOTAL LIABILITIES
Total Short-Term Liabilities	$451.8M	$238.8M
Total Long-Term Liabilities	$788.4M	$310.7M
Total Liabilities	$1.240B	$549.6M
YoY Change	125.67%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.320B	-$1.175B
YoY Change	97.44%	252.34%
Common Stock	$101.0K	$78.00K
YoY Change	29.49%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.812B	$1.609B
YoY Change
Total Liabilities & Shareholders Equity	$4.067B	$2.172B
YoY Change	87.24%

Cashflow Statement

Concept	2020 Q1	2019 Q1
OPERATING ACTIVITIES
Net Income	-$363.7M	-$167.6M
YoY Change	116.97%	60.27%
Depreciation, Depletion And Amortization	$7.750M	$3.416M
YoY Change	126.87%	52.23%
Cash From Operating Activities	-$341.9M	-$172.0M
YoY Change	98.83%	64.57%
INVESTING ACTIVITIES
Capital Expenditures	$21.53M	$21.83M
YoY Change	-1.35%	125.12%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$1.115B	$172.4M
YoY Change	-746.67%	-143.72%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$2.162B
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$2.802B	$42.96M
YoY Change	6422.13%	-94.38%
NET CHANGE
Cash From Operating Activities	-$341.9M	-$172.0M
Cash From Investing Activities	-$1.115B	$172.4M
Cash From Financing Activities	$2.802B	$42.96M
Net Change In Cash	$1.339B	$47.67M
YoY Change	2708.98%	-82.25%
FREE CASH FLOW
Cash From Operating Activities	-$341.9M	-$172.0M
Capital Expenditures	$21.53M	$21.83M
Free Cash Flow	-$363.5M	-$193.8M
YoY Change	87.55%	69.71%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019Q1	bgne	Restricted Net Assets Appropriated To Statutory Reserves RestrictedNetAssetsAppropriatedToStatutoryReserves	0	USD
CY2020Q1	dei	Amendment Flag AmendmentFlag	false
CY2020Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2020Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001651308
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	9500000000	shares
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	9500000000	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	801340698	shares
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1007976816	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	801340698	shares
CY2020Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1007976816	shares
CY2020Q1	dei	Document Type DocumentType	10-Q
CY2020Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2020Q1	dei	Document Period End Date DocumentPeriodEndDate	2020-03-31
CY2020Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2020Q1	dei	Entity File Number EntityFileNumber	001-37686
CY2020Q1	dei	Entity Registrant Name EntityRegistrantName	BEIGENE, LTD.
CY2020Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2020Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1209416
CY2020Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	c/o Mourant Governance Services (Cayman) Limited
CY2020Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	94 Solaris Avenue, Camana Bay
CY2020Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Grand Cayman
CY2020Q1	dei	Entity Address Country EntityAddressCountry	KY
CY2019Q4	us-gaap	Assets Current AssetsCurrent	1172696000	USD
CY2020Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	KY1-1108
CY2020Q1	dei	City Area Code CityAreaCode	345
CY2020Q1	dei	Local Phone Number LocalPhoneNumber	949-4123
CY2020Q1	dei	Security12b Title Security12bTitle	American Depositary Shares, each representing 13 Ordinary Shares, par value $0.0001 per share
CY2020Q1	dei	Trading Symbol TradingSymbol	BGNE
CY2020Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2020Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1008198947	shares
CY2020Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2020Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2020Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020Q1	dei	Entity Shell Company EntityShellCompany	false
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1957101000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	618011000	USD
CY2020Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	282000	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	288000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	1417097000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	364728000	USD
CY2020Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	65620000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	70878000	USD
CY2020Q1	us-gaap	Inventory Net InventoryNet	28775000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	28553000	USD
CY2020Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	126312000	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	90238000	USD
CY2020Q1	us-gaap	Assets Current AssetsCurrent	3595187000	USD
CY2020Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	2435000	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	2476000	USD
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	240331000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	242402000	USD
CY2020Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	91509000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	82520000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5563000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5846000	USD
CY2020Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	37937000	USD
CY2019Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	37894000	USD
CY2020Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	94250000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	68455000	USD
CY2020Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	472025000	USD
CY2019Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	439593000	USD
CY2020Q1	us-gaap	Assets Assets	4067212000	USD
CY2019Q4	us-gaap	Assets Assets	1612289000	USD
CY2020Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	98364000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	122488000	USD
CY2020Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	179331000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	163556000	USD
CY2020Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	19535000	USD
CY2019Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	13454000	USD
CY2020Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	14597000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	10814000	USD
CY2020Q1	bgne	Research And Development Cost Share Liability Current Portion ResearchAndDevelopmentCostShareLiabilityCurrentPortion	128672000	USD
CY2019Q4	bgne	Research And Development Cost Share Liability Current Portion ResearchAndDevelopmentCostShareLiabilityCurrentPortion	0	USD
CY2020Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	11298000	USD
CY2019Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2020Q1	us-gaap	Liabilities Current LiabilitiesCurrent	451797000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	310312000	USD
CY2020Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	81913000	USD
CY2019Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	83311000	USD
CY2020Q1	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	157278000	USD
CY2019Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	157384000	USD
CY2020Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	32967000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	25833000	USD
CY2020Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	10368000	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	10532000	USD
CY2020Q1	bgne	Research And Development Cost Share Liability Noncurrent Portion ResearchAndDevelopmentCostShareLiabilityNoncurrentPortion	460528000	USD
CY2019Q4	bgne	Research And Development Cost Share Liability Noncurrent Portion ResearchAndDevelopmentCostShareLiabilityNoncurrentPortion	0	USD
CY2020Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	45305000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	46562000	USD
CY2020Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	788359000	USD
CY2019Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	323622000	USD
CY2020Q1	us-gaap	Liabilities Liabilities	1240156000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	633934000	USD
CY2020Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q1	us-gaap	Common Stock Value CommonStockValue	101000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	79000	USD
CY2020Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	5138239000	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2925970000	USD
CY2020Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-6548000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-8001000	USD
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2319578000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1955843000	USD
CY2019Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1728000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-363385000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-167550000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1554000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	2812214000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	962205000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	519000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-364939000	USD
CY2019Q1	us-gaap	Profit Loss ProfitLoss	-168069000	USD
CY2020Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1204000	USD
CY2019Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-429000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-363735000	USD
CY2020Q1	us-gaap	Minority Interest MinorityInterest	14842000	USD
CY2019Q4	us-gaap	Minority Interest MinorityInterest	16150000	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2827056000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	978355000	USD
CY2020Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4067212000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1612289000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	52059000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	77833000	USD
CY2020Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	14149000	USD
CY2019Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	15261000	USD
CY2020Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	304302000	USD
CY2019Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	178351000	USD
CY2020Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	107081000	USD
CY2019Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	57645000	USD
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	283000	USD
CY2019Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	331000	USD
CY2020Q1	us-gaap	Costs And Expenses CostsAndExpenses	425815000	USD
CY2019Q1	us-gaap	Costs And Expenses CostsAndExpenses	251588000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-373756000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-173755000	USD
CY2020Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	6690000	USD
CY2019Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	4477000	USD
CY2020Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3681000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-167640000	USD
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.36
CY2019Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.22
CY2020Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	1005347581	shares
CY2019Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	774750255	shares
CY2020Q1	bgne	Earnings Per American Depository Share EarningsPerAmericanDepositoryShare	-4.70
CY2019Q1	bgne	Earnings Per American Depository Share EarningsPerAmericanDepositoryShare	-2.81
CY2020Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-206000	USD
CY2020Q1	bgne	Weighted Average Number Of American Depository Shares Outstanding WeightedAverageNumberOfAmericanDepositorySharesOutstanding	77334429	shares
CY2019Q1	bgne	Weighted Average Number Of American Depository Shares Outstanding WeightedAverageNumberOfAmericanDepositorySharesOutstanding	59596173	shares
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-364939000	USD
CY2019Q1	us-gaap	Profit Loss ProfitLoss	-168069000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-4349000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	3755000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	5698000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	685000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-363590000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-163629000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1308000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-535000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-362282000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-163094000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-364939000	USD
CY2019Q1	us-gaap	Profit Loss ProfitLoss	-168069000	USD
CY2020Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7750000	USD
CY2019Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3416000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	38255000	USD
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	26392000	USD
CY2020Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2022000	USD
CY2019Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
CY2020Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	6964000	USD
CY2019Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0	USD
CY2020Q1	bgne	Acquired In Process Research And Development AcquiredInProcessResearchAndDevelopment	43000000	USD
CY2019Q1	bgne	Acquired In Process Research And Development AcquiredInProcessResearchAndDevelopment	29000000	USD
CY2020Q1	bgne	Amortizationof Research And Development Financing Liability AmortizationofResearchAndDevelopmentFinancingLiability	-27634000	USD
CY2019Q1	bgne	Amortizationof Research And Development Financing Liability AmortizationofResearchAndDevelopmentFinancingLiability	0	USD
CY2020Q1	bgne	Interest Expense Operating Activities InterestExpenseOperatingActivities	2572000	USD
CY2019Q1	bgne	Interest Expense Operating Activities InterestExpenseOperatingActivities	1858000	USD
CY2019Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-983000	USD
CY2020Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-1105000	USD
CY2019Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-3218000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3236000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	17920000	USD
CY2020Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	222000	USD
CY2019Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-3102000	USD
CY2020Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	36075000	USD
CY2019Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5772000	USD
CY2020Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-6212000	USD
CY2019Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4265000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1339043000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	47670000	USD
CY2020Q1	bgne	Increase Decrease In Operating Lease Rightof Use Asset IncreaseDecreaseInOperatingLeaseRightofUseAsset	8990000	USD
CY2019Q1	bgne	Increase Decrease In Operating Lease Rightof Use Asset IncreaseDecreaseInOperatingLeaseRightofUseAsset	1588000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	2710000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	10212000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-21450000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-20364000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	15775000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-8790000	USD
CY2020Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	6080000	USD
CY2019Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	969000	USD
CY2020Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	0	USD
CY2019Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-2238000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	10917000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	1550000	USD
CY2020Q1	bgne	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1256000	USD
CY2019Q1	bgne	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	892000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-341944000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-171975000	USD
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	21533000	USD
CY2019Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	21828000	USD
CY2020Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	1307179000	USD
CY2019Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	487354000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	256743000	USD
CY2019Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	710598000	USD
CY2020Q1	bgne	Payments To Purchase In Process Research And Development PaymentsToPurchaseInProcessResearchAndDevelopment	43000000	USD
CY2019Q1	bgne	Payments To Purchase In Process Research And Development PaymentsToPurchaseInProcessResearchAndDevelopment	29000000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1114969000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	172416000	USD
CY2020Q1	bgne	Proceeds From Issuance Of Common Stock Net Of Underwriter Discount ProceedsFromIssuanceOfCommonStockNetOfUnderwriterDiscount	2162407000	USD
CY2019Q1	bgne	Proceeds From Issuance Of Common Stock Net Of Underwriter Discount ProceedsFromIssuanceOfCommonStockNetOfUnderwriterDiscount	0	USD
CY2020Q1	bgne	Proceeds From Research And Development Financing Liability ProceedsFromResearchAndDevelopmentFinancingLiability	616834000	USD
CY2019Q1	bgne	Proceeds From Research And Development Financing Liability ProceedsFromResearchAndDevelopmentFinancingLiability	0	USD
CY2020Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
CY2019Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	36695000	USD
CY2020Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	11298000	USD
CY2019Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	0	USD
CY2020Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	11629000	USD
CY2019Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	6269000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2802168000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	42964000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	620775000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	26392000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	788383000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	4440000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	740713000	USD
CY2019Q1	us-gaap	Profit Loss ProfitLoss	-168069000	USD
CY2019Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1622679000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1959818000	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1957101000	USD
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	764492000	USD
CY2020Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	282000	USD
CY2019Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	14900000	USD
CY2020Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	2435000	USD
CY2019Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	8991000	USD
CY2020Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	531000	USD
CY2019Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	360000	USD
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet	1136000	USD
CY2019Q1	us-gaap	Interest Paid Net InterestPaidNet	888000	USD
CY2020Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	26412000	USD
CY2019Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	32462000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	978355000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2162407000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	11629000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	38255000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1349000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-364939000	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2827056000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1753647000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	6269000	USD
CY2020Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of estimates</span></div><div style="line-height:120%;padding-bottom:12px;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Areas where management uses subjective judgment include, but are not limited to, estimating the useful lives of long-lived assets, estimating variable consideration in product sales and collaboration revenue arrangements, identifying separate accounting units and the standalone selling price of each performance obligation in the Company’s revenue arrangements, estimating the fair value of net assets acquired in business combinations, assessing the impairment of long-lived assets, share-based compensation expenses, realizability of deferred tax assets, estimating uncertain tax positions, measurement of right-of-use assets and lease liabilities and the fair value of financial instruments. Management bases the estimates on historical experience, known trends and various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from these estimates.</span></div>
CY2020Q1	bgne	Upfront Payments For Collaboration UpfrontPaymentsForCollaboration	43000000	USD
CY2019Q1	bgne	Upfront Payments For Collaboration UpfrontPaymentsForCollaboration	10000000	USD
CY2020Q1	bgne	Milestone Payments MilestonePayments	5000000	USD
CY2019Q1	bgne	Milestone Payments MilestonePayments	0	USD
CY2020Q1	bgne	Upfront And Milestone Payments UpfrontAndMilestonePayments	48000000	USD
CY2019Q1	bgne	Upfront And Milestone Payments UpfrontAndMilestonePayments	10000000	USD
CY2020Q1	bgne	Upfront Payments For Collaboration UpfrontPaymentsForCollaboration	40000000	USD
CY2020Q1	us-gaap	Restricted Cash RestrictedCash	2717000	USD
CY2020Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	1410129000	USD
CY2020Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	6968000	USD
CY2020Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	1417097000	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	363440000	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1288000	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2020Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2022000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	364728000	USD
CY2020Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	444000	USD
CY2019Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	0	USD
CY2020Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	28331000	USD
CY2019Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	28553000	USD
CY2020Q1	us-gaap	Inventory Net InventoryNet	28775000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	28553000	USD
CY2020Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	260728000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	258156000	USD
CY2020Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	43375000	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	36709000	USD
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	240331000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	242402000	USD
CY2020Q1	us-gaap	Depreciation Depreciation	7467000	USD
CY2019Q1	us-gaap	Depreciation Depreciation	3085000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8316000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2753000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5563000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8316000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2470000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5846000	USD
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	283000	USD
CY2019Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	331000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	563000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	750000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	750000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	750000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	750000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	2000000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1554000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	519000	USD
CY2020Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	5586000	USD
CY2020Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	5003000	USD
CY2020Q1	bgne	Unrecognized Tax Benefits Increase Resulting From Tax Credit And Incentives UnrecognizedTaxBenefitsIncreaseResultingFromTaxCreditAndIncentives	369000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2020Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2022000	USD
CY2020Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	USD
CY2020Q1	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	0	USD
CY2019Q4	bgne	Prepaid Construction Cost PrepaidConstructionCost	24881000	USD
CY2020Q1	bgne	Rental Deposits And Other RentalDepositsAndOther	3397000	USD
CY2020Q1	bgne	Prepaid Research And Development Costs PrepaidResearchAndDevelopmentCosts	75867000	USD
CY2019Q4	bgne	Prepaid Research And Development Costs PrepaidResearchAndDevelopmentCosts	69715000	USD
CY2020Q1	us-gaap	Prepaid Taxes PrepaidTaxes	17392000	USD
CY2019Q4	us-gaap	Prepaid Taxes PrepaidTaxes	9498000	USD
CY2020Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	6414000	USD
CY2019Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	0	USD
CY2020Q1	us-gaap	Interest Receivable Current InterestReceivableCurrent	5941000	USD
CY2019Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	1932000	USD
CY2020Q1	us-gaap	Prepaid Insurance PrepaidInsurance	4298000	USD
CY2019Q4	us-gaap	Prepaid Insurance PrepaidInsurance	0	USD
CY2020Q1	bgne	Prepaid Manufacturing Costs PrepaidManufacturingCosts	3525000	USD
CY2019Q4	bgne	Prepaid Manufacturing Costs PrepaidManufacturingCosts	0	USD
CY2020Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	12875000	USD
CY2019Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	9093000	USD
CY2020Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	126312000	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	90238000	USD
CY2020Q1	us-gaap	Goodwill Goodwill	109000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	109000	USD
CY2020Q1	bgne	Prepayment Of Long Term Asset PrepaymentOfLongTermAsset	20421000	USD
CY2019Q4	bgne	Prepayment Of Long Term Asset PrepaymentOfLongTermAsset	10289000	USD
CY2020Q1	bgne	Prepaid Construction Cost PrepaidConstructionCost	25963000	USD
CY2020Q1	us-gaap	Value Added Tax Receivable Noncurrent ValueAddedTaxReceivableNoncurrent	32396000	USD
CY2019Q4	us-gaap	Value Added Tax Receivable Noncurrent ValueAddedTaxReceivableNoncurrent	29967000	USD
CY2019Q4	bgne	Rental Deposits And Other RentalDepositsAndOther	3209000	USD
CY2020Q1	us-gaap	Long Term Investments LongTermInvestments	11964000	USD
CY2019Q4	us-gaap	Long Term Investments LongTermInvestments	0	USD
CY2020Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	94250000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	68455000	USD
CY2020Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	27272000	USD
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	54156000	USD
CY2020Q1	bgne	Accrued Liabilities External Research And Development AccruedLiabilitiesExternalResearchAndDevelopment	53428000	USD
CY2019Q4	bgne	Accrued Liabilities External Research And Development AccruedLiabilitiesExternalResearchAndDevelopment	62794000	USD
CY2020Q1	bgne	Cash Payments Payable Related To Funding Commitments CashPaymentsPayableRelatedToFundingCommitments	56000000	USD
CY2019Q4	bgne	Cash Payments Payable Related To Funding Commitments CashPaymentsPayableRelatedToFundingCommitments	0	USD
CY2020Q1	bgne	Accrued Expenses Commercial Activities AccruedExpensesCommercialActivities	18522000	USD
CY2019Q4	bgne	Accrued Expenses Commercial Activities AccruedExpensesCommercialActivities	25645000	USD
CY2020Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	11944000	USD
CY2019Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	9648000	USD
CY2020Q1	bgne	Accrued Sales Rebates And Returns Current AccruedSalesRebatesAndReturnsCurrent	4014000	USD
CY2019Q4	bgne	Accrued Sales Rebates And Returns Current AccruedSalesRebatesAndReturnsCurrent	3198000	USD
CY2020Q1	bgne	Accrued Professional Fees And Other Current AccruedProfessionalFeesAndOtherCurrent	8151000	USD
CY2019Q4	bgne	Accrued Professional Fees And Other Current AccruedProfessionalFeesAndOtherCurrent	8115000	USD
CY2020Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	179331000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	163556000	USD
CY2020Q1	bgne	Government Grants Or Incentives Received And Deferred Noncurrent GovernmentGrantsOrIncentivesReceivedAndDeferredNoncurrent	45134000	USD
CY2019Q4	bgne	Government Grants Or Incentives Received And Deferred Noncurrent GovernmentGrantsOrIncentivesReceivedAndDeferredNoncurrent	46391000	USD
CY2020Q1	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	171000	USD
CY2019Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	171000	USD
CY2020Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	45305000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	46562000	USD
CY2019Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.22
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-363735000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-167640000	USD
CY2020Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	1005347581	shares
CY2019Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	774750255	shares
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.36
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	38255000	USD
CY2019Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	26392000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	2693000	USD
CY2020Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	1240000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1453000	USD
CY2020Q1	bgne	Restricted Net Assets Minimum Required Statutory Reserve Of Annual After Tax Profit Percentage RestrictedNetAssetsMinimumRequiredStatutoryReserveOfAnnualAfterTaxProfitPercentage	0.10
CY2020Q1	bgne	Restricted Net Assets Required Statutory Reserve As Percentage Of Registered Capital RestrictedNetAssetsRequiredStatutoryReserveAsPercentageOfRegisteredCapital	0.50
CY2020Q1	bgne	Restricted Net Assets Appropriated To Statutory Reserves RestrictedNetAssetsAppropriatedToStatutoryReserves	0	USD
CY2020Q1	bgne	Restricted Net Assets Minimum Required Statutory Reserve Of Annual After Tax Profit Percentage RestrictedNetAssetsMinimumRequiredStatutoryReserveOfAnnualAfterTaxProfitPercentage	0.10
CY2020Q1	us-gaap	Unrecorded Unconditional Purchase Obligation Balance Sheet Amount UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount	117325000	USD
CY2020Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	52059000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	77833000	USD

Files In Submission

Name	View Source	Status
0001651308-20-000056-index-headers.html	Edgar Link	pending
0001651308-20-000056-index.html	Edgar Link	pending
0001651308-20-000056.txt	Edgar Link	pending
0001651308-20-000056-xbrl.zip	Edgar Link	pending
beigene2020q110-q.htm	Edgar Link	pending
beigene2020q110-q_htm.xml	Edgar Link	completed
bgne-20200331.xsd	Edgar Link	pending
bgne-20200331_cal.xml	Edgar Link	unprocessable
bgne-20200331_def.xml	Edgar Link	unprocessable
bgne-20200331_lab.xml	Edgar Link	unprocessable
bgne-20200331_pre.xml	Edgar Link	unprocessable
exhibit102-employmenta.htm	Edgar Link	pending
exhibit103-beigenexind.htm	Edgar Link	pending
exhibit311.htm	Edgar Link	pending
exhibit312.htm	Edgar Link	pending
exhibit321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ONC
BeiGene, Ltd. Stock $onc

2020 Q1 Form 10-Q Financial Statement

#000165130820000056 Filed on May 11, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ONC BeiGene, Ltd. Stock $onc

2020 Q1 Form 10-Q Financial Statement

#000165130820000056 Filed on May 11, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ONC
BeiGene, Ltd. Stock $onc